GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thermo Fisher Scientific Inc (LIM:TMO) » Definitions » Valuation Rank

Thermo Fisher Scientific (LIM:TMO) Valuation Rank


View and export this data going back to 2020. Start your Free Trial

What is Thermo Fisher Scientific Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Thermo Fisher Scientific Valuation Rank Related Terms

Thank you for viewing the detailed overview of Thermo Fisher Scientific's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Thermo Fisher Scientific (LIM:TMO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thermo Fisher Scientific Inc (LIM:TMO) » Definitions » Valuation Rank
Comparable Companies
DHR IQV IDXX A MTD ICLR ILMN WAT LH DGX XSWX:LONN SHSE:603259 XPAR:BIM RVTY MEDP CRL XPAR:ERF NTRA EXAS QGEN
Traded in Other Exchanges
TMO:USA TMO:Mexico TN8:Germany TMOS34:Brazil TMO:Argentina
Address
168 Third Avenue, Waltham, MA, USA, 02451
Website
https://www.thermofisher.com
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2023 (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (10%); life science solutions (24%); and lab products and services, which includes CRO services (54%).